跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-TRIENTINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-TRIENTINE
Authorized
STANDARD
MAR-TRIENTINE
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7c18c7254287ff11
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
7c18c7254287ff11
Drug Approval Canada Name
MAR-TRIENTINE
Product Name
MAR-TRIENTINE
Status
Marketed
Status Date
2020-11-10
Original Market Date
2020-11-10
Din
02504855
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
64:00.00
Atc Original
A16AX12 TRIENTINE
Atc Name
a 16 ax 12
Aig Number
0162478001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
TRIENTINE HYDROCHLORIDE
250 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7c18c7254287ff11
Type
Standard
Back to Health Canada Approvals